Liverpool Cancer Therapy Centre, Liverpool, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
J Med Imaging Radiat Oncol. 2022 Apr;66(3):442-454. doi: 10.1111/1754-9485.13357. Epub 2021 Nov 30.
This study aims to report on the surgical and radiotherapy patterns of breast cancer care in New South Wales (NSW) and Australian Capital Territory (ACT) in Australia, to identify factors that impact on utilisation of evidence-based treatment and to report on the overall survival (OS) rate and the influencing factors on OS.
Cancer registry data linked to hospital records for all patients with breast cancer diagnosis in NSW and ACT between 2009 and 2014 were used to calculate rates of breast conserving surgery (BCS), mastectomy, sentinel lymph node biopsy (SLNB), axillary lymph node dissection (ALND) and radiotherapy. Multivariate analysis used to identify factors that led to variations in care. 5-year OS was calculated and cox regression model assessed factors that influenced survival.
Data for 30,337 patients were analysed. BCS and mastectomy rates were 64% and 36%, respectively. The SLNB, ALND and ALND after SLNB rates were 61.5%, 32.1% and 6.4%, respectively. Radiotherapy was utilised in 63%. Younger age, socio-economic disadvantage, longer distance to a radiotherapy facility and overseas place of birth were factors that predicted for increased rates of mastectomy and ALND. Radiotherapy was more likely to be utilised in later years of diagnosis, patients between 40-69 years old, and those who lived in major cities and closer to a radiotherapy facility. 5-year OS was 80.5%. Older patients, the socioeconomically disadvantaged and those advanced tumours had worse survival.
Variations in breast cancer care continue to exist in certain patient groups that we identified. Targeted strategic planning and further research to identify other drivers of existing disparities remain a priority.
本研究旨在报告澳大利亚新南威尔士州(NSW)和澳大利亚首都领地(ACT)的乳腺癌治疗的手术和放疗模式,确定影响循证治疗应用的因素,并报告总生存率(OS)及其影响因素。
使用 2009 年至 2014 年期间 NSW 和 ACT 所有乳腺癌患者的癌症登记数据与医院记录进行关联,以计算保乳手术(BCS)、乳房切除术、前哨淋巴结活检(SLNB)、腋窝淋巴结清扫术(ALND)和放疗的比例。采用多变量分析来确定导致治疗差异的因素。计算 5 年 OS,并使用 Cox 回归模型评估影响生存的因素。
分析了 30337 名患者的数据。BCS 和乳房切除术的比例分别为 64%和 36%。SLNB、ALND 和 SLNB 后 ALND 的比例分别为 61.5%、32.1%和 6.4%。放疗的使用率为 63%。年龄较小、社会经济劣势、距放疗机构的距离较长和出生地在海外是预测乳房切除术和 ALND 比例增加的因素。放疗更有可能在诊断后的后期使用,患者年龄在 40-69 岁之间,居住在主要城市和靠近放疗机构的患者。5 年 OS 为 80.5%。年龄较大的患者、社会经济劣势的患者和肿瘤晚期的患者生存率较差。
我们确定的某些患者群体中,乳腺癌治疗的差异仍然存在。有针对性的战略规划和进一步研究,以确定现有差异的其他驱动因素,仍然是当务之急。